These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. In vitro restoration by interleukin-2 (IL-2) of the impaired natural killer cell activities, IL-2 receptor expression, and T cell proliferation in hemophilia. Zaizov R; Cohen IJ; Luria D; Trainin N; Umiel T J Biol Response Mod; 1986 Aug; 5(4):339-50. PubMed ID: 3090209 [TBL] [Abstract][Full Text] [Related]
23. The acquired immune deficiency syndrome: viral infections and etiology. Armstrong D Prog Med Virol; 1984; 30():1-13. PubMed ID: 6087407 [No Abstract] [Full Text] [Related]
24. [Tonsils and viral diseases]. Sesterhenn K Dtsch Z Mund Kiefer Gesichtschir; 1984; 8(2):93-9. PubMed ID: 6098399 [No Abstract] [Full Text] [Related]
25. Human virus-specific CD8+ T cells: diversity specialists. van Leeuwen EM; de Bree GJ; ten Berge IJ; van Lier RA Immunol Rev; 2006 Jun; 211():225-35. PubMed ID: 16824131 [TBL] [Abstract][Full Text] [Related]
26. Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: a comparative study. Fawaz LM; Sharif-Askari E; Menezes J J Immunol; 1999 Oct; 163(8):4473-80. PubMed ID: 10510389 [TBL] [Abstract][Full Text] [Related]
27. Patient, disease and immune response. Burgio GR Boll Ist Sieroter Milan; 1974; 53(1):suppl:119-20. PubMed ID: 4546879 [No Abstract] [Full Text] [Related]
29. [Apoptosis and human viral infections]. Wattre P; Bert V; Hober D Ann Biol Clin (Paris); 1996; 54(5):189-97. PubMed ID: 8869358 [TBL] [Abstract][Full Text] [Related]
30. [Mechanisms of viral diseases and means of natural defense]. Morinet F Rev Prat; 1997 Mar; 47(6):618-21. PubMed ID: 9183935 [TBL] [Abstract][Full Text] [Related]
32. Immune response to tumour antigens. McConnell I Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(3):381-4. PubMed ID: 347640 [TBL] [Abstract][Full Text] [Related]
33. Viral immune evasion: a masterpiece of evolution. Vossen MT; Westerhout EM; Söderberg-Nauclér C; Wiertz EJ Immunogenetics; 2002 Nov; 54(8):527-42. PubMed ID: 12439615 [TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease. Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic approaches to patients with AIDS. Lane HC; Masur H; Gelmann EP; Fauci AS Cancer Res; 1985 Sep; 45(9 Suppl):4674s-4676s. PubMed ID: 2990706 [TBL] [Abstract][Full Text] [Related]
36. [T-cells in the immune system. 2: Control of bacterial and viral infections]. Uhl D Med Monatsschr Pharm; 1991 Jul; 14(7):195-6. PubMed ID: 1832203 [No Abstract] [Full Text] [Related]
37. How chronic viral infections impact on antigen-specific T-cell responses. Frebel H; Richter K; Oxenius A Eur J Immunol; 2010 Mar; 40(3):654-63. PubMed ID: 20077405 [TBL] [Abstract][Full Text] [Related]
38. Control of human viral infections by natural killer cells. Jost S; Altfeld M Annu Rev Immunol; 2013; 31():163-94. PubMed ID: 23298212 [TBL] [Abstract][Full Text] [Related]
40. Pathogen specific T-lymphocytes for the reconstitution of the immunocompromised host. Li Pira G; Kapp M; Manca F; Einsele H Curr Opin Immunol; 2009 Oct; 21(5):549-56. PubMed ID: 19800209 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]